Document is current
Any future updates will be listed below
-
Authors
Aristizábal-Colorado, David https://orcid.org/0000-0002-8361-7748
Ocampo-Posada, Martín https://orcid.org/0000-0001-7154-3692
Rivera-Martínez, Wilfredo Antonio https://orcid.org/0000-0002-6079-6974
Corredor-Rengifo, David https://orcid.org/0000-0003-1750-5921
Rico-Fontalvo, Jorge https://orcid.org/0000-0002-2852-1241
Gómez-Mesa, Juan Esteban https://orcid.org/0000-0002-6635-6224
Duque-Ossman, John Jairo https://orcid.org/0000-0003-1097-5963
Abreu-Lomba, Alin https://orcid.org/0000-0002-7377-4969
- License Information
-
More Information
Article History
Accepted: 6 August 2024
First Online: 24 August 2024
Declarations
:
: Jorge Rico Fontalvo declares that he has received honoraria for lectures for Astra Zeneca, Boehringer Ingelheim, Novo Nordisk, Lilly, Sanofi, Novartis, Abbvie, Merck, and Bayer. He has participated in advisory boards with AZ, Boehringer Ingelheim, Bayer, and Novo Nordisk. John Jairo Duque Ossman declares that he has received honoraria for lectures for Adium Pharma. The other authors have no conflicts of interest to disclose.
: The authors report that this work was carried out with their resources.
: All the bibliographic content is available on the reported source.
: Not applicable.
: Not applicable.
: Not applicable.
: The images were developed and adapted using the Microsoft 365 (office) program licensed by Universidad Libre.
: David Aristizabal-Colorado: bibliography review, development of the first manuscript, and splicing of the work team. Martín Ocampo-Posada: bibliography review and internal medicine review board. Wilfredo Antonio Rivera-Martínez: bibliography review and internal medicine review board. David Corredor-Rengifo: bibliography review and graphic development. Jorge Rico-Fontalvo: nephrology reviewer. Juan Esteban Gómez-Mesa: cardiology reviewer. John Jairo Duque-Ossman: endocrinology reviewer. Alin Abreu-Lomba: endocrinology reviewer and splicing of the work team.
